BRENTUXIMAB VEDOTIN PLUS BENDAMUSTINE AS A SALVAGE TREATMENT REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA LaCasce, A., Bociek, G., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S., Crosswell, H., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O'Connor, O. A., Josephson, N., Advani, R. FERRATA STORTI FOUNDATION. 2016: 45–46

View details for Web of Science ID 000392549000108